The journey from a promising lead compound to a marketable Active Pharmaceutical Ingredient (API) is intricate, relying heavily on the availability and quality of specialized chemical intermediates. Among these, chiral building blocks are indispensable for constructing molecules with precise stereochemistry, which directly influences their pharmacological activity. Boc-(R)-3-Amino-4-(3-cyanophenyl)-butyric Acid stands out as a key player in this domain.

This article delves into the significance of Boc-(R)-3-Amino-4-(3-cyanophenyl)-butyric Acid (CAS: 269726-83-2) for API synthesis. As a protected amino acid derivative with a cyano-substituted phenyl group, it offers unique functionalities that are leveraged in the construction of complex drug molecules. R&D scientists often seek this compound for its specific structural attributes, enabling the introduction of desired chiral centers and functional moieties. For professionals looking to buy Boc-(R)-3-Amino-4-(3-cyanophenyl)-butyric Acid, understanding its applications in API manufacturing is crucial for justifying the investment in this specialized intermediate.

The market availability and pricing of such compounds are significant considerations for procurement managers. Companies often research “Boc-(R)-3-Amino-4-(3-cyanophenyl)-butyric Acid price” and look for reliable suppliers who can meet stringent quality requirements, typically a purity of 97%. Identifying a trusted Boc-(R)-3-Amino-4-(3-cyanophenyl)-butyric Acid manufacturer, especially within China's competitive chemical industry, is key to securing a consistent and high-quality supply chain. This involves evaluating potential partners for their production capacity, quality control systems, and ability to handle bulk purchase orders efficiently.

The demand for advanced pharmaceutical building blocks like Boc-(R)-3-Amino-4-(3-cyanophenyl)-butyric Acid underscores the growing complexity of modern drug development. Its role in synthesizing molecules targeting various therapeutic areas makes it a sought-after commodity. By partnering with a reputable Boc-(R)-3-Amino-4-(3-cyanophenyl)-butyric Acid supplier, pharmaceutical companies can ensure the timely progression of their drug candidates through clinical trials and towards market launch. This strategic sourcing approach not only streamlines the R&D process but also contributes to the overall efficiency and cost-effectiveness of API production.